Telik Inc Revenue Growth Rates (TELK), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Telik Inc  (TELK)
 

TELK's Revenue Growth by Quarter and Year

Telik Inc's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TELK Revenue (in millions $) FY 2014 FY 2013 FY 2012 FY 2011
4th Quarter December -
3rd Quarter September -
2nd Quarter June -
1st Quarter March 0.00
FY 0.00





TELK Revenue first quarter 2014 Y/Y Growth Comment
Telik Inc in the first quarter 2014 recorded of $ 0.00 millions.

According to the results reported in the first quarter 2014, Telik Inc achieved the best Revenue growth in Biotechnology & Pharmaceuticals industry. While Telik Inc' s Revenue no change of 0% ranks overall at the positon no. in the first quarter 2014.


TELK Revenue ( Y/Y Growth %) 2014
 2013 2012 2011
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY   - - - -

Financial Statements
Telik Inc's first quarter 2014 Revenue $ 0.00 millions TELK's Income Statement
Telik Inc's first quarter 2013 Revenue $ 0.00 millions Quarterly TELK's Income Statement


TELK Revenue (Quarter on Quarter Growth %)

 2014
 2013 2012 2011
4th Quarter December - - - -
3rd Quarter September - - - -
2nd Quarter June - - - -
1st Quarter March - - - -
FY (Year on Year)   - - - -


Back to TELK Growth rate Comparisons >> Back to TELK Growth rate Comparisons >>


Revenue first quarter 2014 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Revenue first quarter 2014 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Revenue Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Revenue by Quarter for the Fiscal Years 2011, 2012, 2013, 2014

Telik Inc's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


TELK's I. Quarter Q/Q Revenue Comment
Recent accomplishment of 0.00 millions by Telik Inc come out even worse considering the 0.06 millions a quarter before.

Within Biotechnology & Pharmaceuticals industry Telik Inc achieved highest sequential Revenue growth. While Telik Inc's Revenue growth quarter on quarter, overall rank is .


Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #
Revenue Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


TELK's I. Quarter Q/Q Revenue Comment
Recent accomplishment of 0.00 millions by Telik Inc come out even worse considering the 0.06 millions a quarter before.

Within Biotechnology & Pharmaceuticals industry Telik Inc achieved highest sequential Revenue growth. While Telik Inc's Revenue growth quarter on quarter, overall rank is .


Telik Inc's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2014)		 12 Months Ending
(Mar 31 2014)		 12 Months Ending
(Dec 31 2013)		 12 Months Ending
(Sep 30 2013)		 12 Months Ending
(Jun 30 2013)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.00
Y / Y Revenue Growth (TTM) - - - - -
Year on Year Revenue Growth Overall Ranking # # # # #
Seqeuential Revenue Change (TTM) - - - - -
Seq. Revenue Growth (TTM) Overall Ranking # # # # #


Cumulative Revenue growth Comment
In the Jun 30 2014 period, Telik Inc's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Telik Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
 0 %
0 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Revenue growth Comment
In the Jun 30 2014 period, Telik Inc's cumulative trailing twelve month Revenue remained unchanged compare to the same period a year ago.

Telik Inc achieved highest trailing twelve month year on year Revenue growth. While overall Revenue growth ranking, remained unchanged compare to the previous quarter at no. .


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Pharmaceuticals Industry #
Healthcare Sector #
Overall #

Revenue TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 






Other Revenue Growth
Biotechnology & Pharmaceuticals Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
TELK's Revenue Growth Ratio versus Biotechnology & Pharmaceuticals Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue no change for the quarter ending Mar 31 2018 within Healthcare SectorY/Y Change %Revenue for the quarter ending Mar 31 2018
Rti Surgical Holdings Inc -0.07%$ -0.070 millions
Stereotaxis Inc -0.09%$ -0.087 millions
Fate Therapeutics Inc -0.10%$ -0.097 millions
Diversicare Healthcare Services Inc -0.15%$ -0.152 millions
Tg Therapeutics Inc -0.25%$ -0.249 millions
Lisata Therapeutics Inc -0.29%$ -0.287 millions
Incyte Corporation-0.47%$ -0.469 millions
Oxford Immunotec Global Plc-0.63%$ -0.628 millions
Integrated Biopharma Inc-0.74%$ -0.742 millions
Endologix Inc-0.77%$ -0.770 millions
Standard Biotools Inc -1.12%$ -1.116 millions
Sonida Senior Living Inc -1.16%$ -1.161 millions
Mylan N v -1.29%$ -1.287 millions
Allied Healthcare Products inc -1.33%$ -1.333 millions
Star Equity Holdings Inc -1.45%$ -1.451 millions
Myriad Genetics Inc -1.73%$ -1.727 millions
Sunlink Health Systems Inc -2.06%$ -2.059 millions
Achari Ventures Holdings Corp I-2.10%$ -2.097 millions
Adicet Bio Inc -2.17%$ -2.172 millions
Jaguar Health Inc -2.20%$ -2.195 millions
Brookdale Senior Living Inc -2.43%$ -2.427 millions
Micron Solutions Inc-2.77%$ -2.772 millions
Vivani Medical Inc -3.27%$ -3.271 millions
Tearlab Corp-3.81%$ -3.805 millions
Conformis inc -3.91%$ -3.906 millions
Opko Health Inc -4.31%$ -4.305 millions
Myokardia Inc -5.23%$ -5.227 millions
Therapeuticsmd Inc -5.32%$ -5.321 millions
Bausch Health Companies Inc -5.41%$ -5.405 millions
Delcath Systems Inc -5.52%$ -5.518 millions


About Telik Inc Revenue Growth Rates (TELK), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: the company’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.